David Pompliano

David Pompliano

Scientific Advisory Board

Pharmaceutical Industry. Entrepreneur.

Entrepreneur-in-Residence at joined Third Rock. He has over 20 years of experience in the biopharmaceutical industry, most recently as CEO of BioLeap, a discovery stage platform technology company. Before that, he was a senior pharmaceutical executive at GlaxoSmithKline and Merck, where he led drug discovery teams that produced pre-clinical credentials for >30 development candidates and four registered anti-infective (Altabax) and oncology (Tykerb, Votrient, Promacta) drugs.

Pompliano earned the BS and PhD degrees in Chemistry from the University of Virginia and from Stanford University, respectively, and conducted research as a National Institutes of Health Postdoctoral Fellow at Harvard University.  He also is Principal and Owner at Sanderling Consulting LLC and serves on the Scientific Advisory Boards of several biotechnology companies.